Fauna Bio, a biotechnology company harnessing animal genomics to improve human health, announced the launch of Fauna Brain™, a proprietary AI platform designed to...
InSilicoTrials, a health tech company developing simulation-based solutions for drug development, announced its acceptance into the Microsoft for Startups Pegasus Program, an, invitation-only initiative...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration with The Abrams...
Former Google DeepMind Director brings over two decades of AI research expertise and industrial leadership to Genesis’ AI platform and high-performing research teams
Genesis Therapeutics,...
Outcomes4Me Inc., the developer of the leading, direct-to-patient, AI-driven platform transforming the cancer-care experience, announced that its German affiliate Outcomes4Me Germany GmbH has acquired...
Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, and Databricks, the Data and AI company, announced...
ValGenesis, Inc., the global innovator in digital validation lifecycle management, announced the launch of ValGenesis Smart GxP™, the first AI-enabled platform purpose-built to unify...
Tevogen, provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™.
Tevogen.AI™ aims to integrate advanced machine learning and predictive modeling into Tevogen...
The initiative will apply its massive, multimodal dataset to build models that aim to improve diagnostic, prognostic, and predictive modeling
Tempus AI, Inc., a technology...